{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:09:12Z","timestamp":1772172552824,"version":"3.50.1"},"reference-count":0,"publisher":"Esmon Publicidad, SA","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Investig Allergol Clin Immunol"],"published-print":{"date-parts":[[2021,2,16]]},"DOI":"10.18176\/jiaci.0667","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T18:40:43Z","timestamp":1610476843000},"page":"92-93","source":"Crossref","is-referenced-by-count":29,"title":["Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines"],"prefix":"10.18176","volume":"31","author":[{"given":"ML","family":"Caballero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Quirce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7491","published-online":{"date-parts":[[2021,2,17]]},"container-title":["Journal of Investigational Allergology and Clinical Immunology"],"original-title":[],"deposited":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T17:56:34Z","timestamp":1613498194000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jiaci.org\/summary\/vol31-issue1-num2197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2,17]]},"published-print":{"date-parts":[[2021,2,16]]}},"URL":"https:\/\/doi.org\/10.18176\/jiaci.0667","relation":{},"ISSN":["1018-9068"],"issn-type":[{"value":"1018-9068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,16]]}}}